Evidence map›Paper›PMID 38425145›Full record

ArticleEnvironmental microbiology reports2024

Construction of a versatile in vitro cultivation screening platform using human oral microbiota.

Kengo Sasaki, Yasunobu Takeshima, Ayami Fujino, Junya Yamashita, Akira Kimoto, Daisuke Sasaki, Akihiko Kondo, Masaya Akashi, Ryo Okumura

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Environmental microbiology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kengo SasakiBio Palette Co., Ltd, Kobe, Japan.ORCID 0000-0002-5764-1429
Yasunobu TakeshimaBio Palette Co., Ltd, Kobe, Japan.
Ayami FujinoBio Palette Co., Ltd, Kobe, Japan.
Junya YamashitaDepartment of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Akira KimotoDepartment of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Daisuke SasakiGraduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo, Japan.
Akihiko KondoGraduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo, Japan.
Masaya AkashiDepartment of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Ryo OkumuraBio Palette Co., Ltd, Kobe, Japan.
Kobe University · JPJapan Bio Products (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed a simulation model of human oral microbiota using Bio Palette oral medium (BPOM) containing 0.02% glucose and lower bacterial nitrogen sources, derived from saliva and dental plaque. By decreasing the concentration of Gifu anaerobic medium (GAM) from 30 to 10 g L

Indexed as

Fusobacterium nucleatumMicrobiotaBiofilmsHumansPorphyromonas gingivalisSaliva

Identifiers

PMID38425145
PMCPMC10904971
OpenAlexW4392353202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.